These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38664766)
1. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. Wang Y; Liu QF; Wu DP; Xu ZL; Han TT; Sun YQ; Huang F; Fan ZP; Xu N; Chen F; Zhao Y; Kong Y; Mo XD; Xu LP; Zhang XH; Liu KY; Huang XJ BMC Med; 2024 Apr; 22(1):176. PubMed ID: 38664766 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial. Zeiser R; Socié G; Schroeder MA; Abhyankar S; Vaz CP; Kwon M; Clausen J; Volodin L; Giebel S; Chacon MJ; Meyers G; Ghosh M; Deeren D; Sanz J; Morariu-Zamfir R; Arbushites M; Lakshminarayanan M; Barbour AM; Chen YB Lancet Haematol; 2022 Jan; 9(1):e14-e25. PubMed ID: 34971577 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Ho VT; Aldridge J; Kim HT; Cutler C; Koreth J; Armand P; Antin JH; Soiffer RJ; Alyea EP Biol Blood Marrow Transplant; 2009 Jul; 15(7):844-50. PubMed ID: 19539216 [TBL] [Abstract][Full Text] [Related]
4. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843 [TBL] [Abstract][Full Text] [Related]
5. [Comparison study on treatment of acute graft-versus-host disease with low-dose methotrexate in combination with low-dose methylprednisolone or standard-dose methylprednisolone]. Wang J; Xu LP; Liu DH; Liu KY; Chen H; Chen YH; Han W; Wang Y; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):512-5. PubMed ID: 22338171 [TBL] [Abstract][Full Text] [Related]
6. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Huang XJ; Jiang Q; Chen H; Xu L; Liu D; Chen Y; Han W; Zhang Y; Liu K; Lu D Bone Marrow Transplant; 2005 Aug; 36(4):343-8. PubMed ID: 15968295 [TBL] [Abstract][Full Text] [Related]
7. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Finke J; Bethge WA; Schmoor C; Ottinger HD; Stelljes M; Zander AR; Volin L; Ruutu T; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Kolb HJ; Bertz H; Egger M; Grishina O; Socié G; Lancet Oncol; 2009 Sep; 10(9):855-64. PubMed ID: 19695955 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Tacrolimus and Cyclosporine Combined With Methotrexate for Graft Versus Host Disease Prophylaxis After Allogeneic Hematopoietic Cell Transplantation. Huang B; Lin X; Zhang Z; Zhang Y; Zheng Z; Zhong C; He X; Chen M Transplantation; 2020 Feb; 104(2):428-436. PubMed ID: 31283681 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention. Hamilton BK; Rybicki LA; Li H; Lucas T; Corrigan D; Kalaycio M; Sobecks R; Hanna R; Rotz SJ; Dean RM; Gerds AT; Jagadeesh D; Brunstein C; Sauter CS; Copelan EA; Majhail NS Blood Adv; 2023 Aug; 7(16):4505-4513. PubMed ID: 37352262 [TBL] [Abstract][Full Text] [Related]
10. Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility. Wang Y; Xu LP; Liu KY; Liu DH; Wang J; Chen H; Chen YH; Han W; Huang XJ Bone Marrow Transplant; 2011 Jun; 46(6):892-8. PubMed ID: 20711243 [TBL] [Abstract][Full Text] [Related]
11. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Chen YB; Mohty M; Zeiser R; Teshima T; Jamy O; Maertens J; Purtill D; Chen J; Cao H; Rossiter G; Jansson J; Fløisand Y Nat Med; 2024 Aug; 30(8):2277-2287. PubMed ID: 38844797 [TBL] [Abstract][Full Text] [Related]
12. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia]. Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123 [TBL] [Abstract][Full Text] [Related]
13. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R; Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417 [TBL] [Abstract][Full Text] [Related]
14. Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial. Dou L; Peng B; Li X; Wang L; Jia M; Xu L; Li F; Liu D Trials; 2022 Jun; 23(1):470. PubMed ID: 35668528 [TBL] [Abstract][Full Text] [Related]
15. Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD. Watkins B; Qayed M; McCracken C; Bratrude B; Betz K; Suessmuth Y; Yu A; Sinclair S; Furlan S; Bosinger S; Tkachev V; Rhodes J; Tumlin AG; Narayan A; Cribbin K; Gillespie S; Gooley TA; Pasquini MC; Hebert K; Kapoor U; Rogatko A; Tighiouart M; Kim S; Bresee C; Choi SW; Davis J; Duncan C; Giller R; Grimley M; Harris AC; Jacobsohn D; Lalefar N; Norkin M; Farhadfar N; Pulsipher MA; Shenoy S; Petrovic A; Schultz KR; Yanik GA; Waller EK; Levine JE; Ferrara JL; Blazar BR; Langston A; Horan JT; Kean LS J Clin Oncol; 2021 Jun; 39(17):1865-1877. PubMed ID: 33449816 [TBL] [Abstract][Full Text] [Related]
16. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease. Gao Z; Fan Z; Liu Z; Ye X; Zeng Y; Xuan L; Huang F; Lin R; Sun J; Liu Q; Xu N Front Immunol; 2024; 15():1408211. PubMed ID: 39021571 [TBL] [Abstract][Full Text] [Related]
17. Mini-dose methotrexate combined with methylprednisolone as a first-line treatment for acute graft-versus-host disease: A phase 2 trial. Xu Z; Mo X; Kong Y; Wen Q; Han T; Lyu M; Xu L; Chang Y; Zhang X; Huang X; Wang Y J Transl Int Med; 2023 Sep; 11(3):255-264. PubMed ID: 37662885 [TBL] [Abstract][Full Text] [Related]
18. Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus. Ashouri K; Fernandez E; Ginosyan A; Feliciano CM; Hom B; Rodman J; Ali A; Ladha A; Woan K; Tam E; Chaudhary P; Yaghmour G Transplant Proc; 2024 Sep; 56(7):1671-1677. PubMed ID: 39174390 [TBL] [Abstract][Full Text] [Related]
19. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Van Lint MT; Uderzo C; Locasciulli A; Majolino I; Scimé R; Locatelli F; Giorgiani G; Arcese W; Iori AP; Falda M; Bosi A; Miniero R; Alessandrino P; Dini G; Rotoli B; Bacigalupo A Blood; 1998 Oct; 92(7):2288-93. PubMed ID: 9746766 [TBL] [Abstract][Full Text] [Related]
20. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation]. Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]